Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2019
Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach
Benyam Muluneh, Daniel R Richardson, Charles Hicks, et al.
Journal of Cellular and Molecular Medicine
|
November 29, 2022
Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
Christopher E Jensen, Nathan D Montgomery, Jonathan Galeotti, et al.
Leukemia & Lymphoma
|
February 4, 2015
Lenalidomide-associated hemolytic anemia
Ming Y Lim, Jay S Raval, Kristy L Richards, et al.
Clinical Case Reports
|
December 3, 2019
Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis
Christopher Trennepohl, Jonathan Sorah, Patrick Eulitt, et al.
Leukemia & Lymphoma
|
April 10, 2014
The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?
Joshua F Zeidner, Marianna Zahurak, Gary L Rosner, et al.
Leukemia Research
|
July 12, 2014
Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)
Joshua F Zeidner, Douglas E Gladstone, Marianna Zahurak, et al.
Annals of Hematology
|
May 8, 2020
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia
Joseph E Maakaron, Michael P Ozga, Gabriel N Mannis, et al.
Hemasphere
|
November 2, 2020
Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 <i>BCR-ABL1</i> Fusion Transcript
Julia W Sheets, Patrick Eulitt, Rong He, et al.
Journal of the National Cancer Institute
|
November 11, 2015
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute
Joshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2017
A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML
Benyam Muluneh, Kaitlyn Buhlinger, Allison M Deal, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2019
Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach
Benyam Muluneh, Daniel R Richardson, Charles Hicks, et al.
Journal of Cellular and Molecular Medicine
|
November 29, 2022
Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
Christopher E Jensen, Nathan D Montgomery, Jonathan Galeotti, et al.
Leukemia & Lymphoma
|
February 4, 2015
Lenalidomide-associated hemolytic anemia
Ming Y Lim, Jay S Raval, Kristy L Richards, et al.
Clinical Case Reports
|
December 3, 2019
Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis
Christopher Trennepohl, Jonathan Sorah, Patrick Eulitt, et al.
Leukemia & Lymphoma
|
April 10, 2014
The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?
Joshua F Zeidner, Marianna Zahurak, Gary L Rosner, et al.
Leukemia Research
|
July 12, 2014
Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)
Joshua F Zeidner, Douglas E Gladstone, Marianna Zahurak, et al.
Annals of Hematology
|
May 8, 2020
Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia
Joseph E Maakaron, Michael P Ozga, Gabriel N Mannis, et al.
Hemasphere
|
November 2, 2020
Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 <i>BCR-ABL1</i> Fusion Transcript
Julia W Sheets, Patrick Eulitt, Rong He, et al.
Journal of the National Cancer Institute
|
November 11, 2015
Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute
Joshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2017
A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML
Benyam Muluneh, Kaitlyn Buhlinger, Allison M Deal, et al.
Page
of 8